Overview of Solicitation
The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices. This Broad Agency Announcement (BAA 75N93024R00020) is an invitation for innovators in the critical field of radiation emergency preparedness.
Key Proposal Information
The goal of this BAA is to develop products for the diagnosis, assessment, mitigation, and/or treatment of radiation injuries to the stage where they are competitive for further development by the Biomedical Advanced Research and Development Authority (BARDA) or acquisition under the Project BioShield Act of 2004. This will enhance readiness for public health emergencies and bolster national preparedness. Specifically, proposals are sought to advance two types of products:
- Biodosimetry devices to detect radiation exposure and assess injuries.
- MCMs to mitigate radiation-induced tissue damage and reduce mortality or major morbidities.
Evaluation Criteria
It is anticipated that candidate biodosimetry devices or lead MCMs will be at various stages of development (from mid-stage research to post-marketing for products that are already approved for other indications). Proposals will be assessed on:
- Data supporting detection, diagnosis, or mitigation of radiation injuries or tissue damage.
- Adequacy of the scientific and technical approach to advance the product toward approval, licensure, or clearance.
- Expertise of personnel and adequacy of facilities and equipment.
- Compliance with Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and robust project management.
Award Information
- Anticipated Awards: 1-2 cost-reimbursement, completion-type contracts.
- Performance Period: Up to 3 years, beginning in March 2026.
- Estimated Funding: Up to $6 million per award over the 3-year period, with average annual costs of approximately $2 million.
Important Deadlines
- BAA Availability: The full BAA will be available on/about December 19, 2024, and will be accessible through sam.gov.
If your company has considered applying for Federal funding, your federal funding journey starts here.
For additional information about EverGlade Consulting, reach out to: [email protected]
